Skip to main content
OpenTrials

Clinical trial condition

Recurrent Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

81 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Acute Myeloid Leukemia trial results

Recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

NCT06484062

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States
View all 22 locations
View Trial Details
Recruiting

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

NCT06222580

Conditions
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation, +9 more
Locations
  • UNC Hospitals, University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
View Trial Details

Related conditions